PTAB
Advanced fields
48 decisions · 442msnewest first
  • PTAB · Jul 7, 2021 · IPR2020-01466 · APJ Melissa A Haapala · IPR · Rehearing

    The Board denied rehearing and left in place the denial of institution on claims 1–12 because petitioner showed no overlooked matter or abuse of discretion.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “On rehearing, the burden of showing that the Decision should be modified lies with Petitioner, the party challenging the Decision. See 37 C.F.R. § 42.71(d). “The request must specifically identify all matters the party believes the Board misapprehended or overlooked, and the place where each matter was previously addressed in a motion, an opposition, a reply, or a sur-reply.” Id. “When rehearing a decision on petition, a panel will review the decision for an abuse of discretion.” 37 C.F.R. § 42.71(c).” slip op. at 2

    • PTAB / AIA Trials › Institution threshold (reasonable likelihood / more likely than not)Institution denied meritsInstitution denied

      “establish Hettstedt discloses the “reconfiguring each remote radio unit.” See Dec. 15. We disagree that we overlooked any arguments presented in the Petition with respect to this limitation. In its analysis of the “reconfiguring each remote radio unit” limitation in the Petition, Petitioner relied on Hettstedt’s disclosure that the CMU controls the frequency allocation of each carrier to the remote radio heads “by changing the MAC address of a specific carrier packet to correspond no longer to a first remote radio head, but instead be addressed to a different radio head in a high traffic area.” See Pet. 22 (citing Ex. 1005, 5:10–11; 3:8–16; 4:35–39). Our Decision expressly addressed Petitioner’s arguments and evidence: After reviewing Petitioner’s analysis and supporting evidence, and Patent Owner’s response, we determine Petitioner fails to establish Hettstedt discloses “reconfiguring each remote radio unit” as we construe the claim (changing the configuration of each remote radio unit). Petitioner relies on Hettstedt’s disclosure that the CMU controls allocation of each carrier by changing the MAC addresses of carrier packets to disclose the recited “reconfiguring.” See Pet. 22. However, while changing the MAC addresses of carrier packets may result in an increase or decrease of the number of carriers assigned to a radio head by the CMU when routing traffic, it does not reconfigure (change) the configuration of the remote radio head itself. As we noted in our analysis of the claim construction of this term, the plain language of the claim requires that the remote radio head itself be reconfigured. Petitioner’s analysis does not address how Hettstedt discloses reconfiguring the remote radio unit itself.” slip op. at 3

    • Claim Construction › Intrinsic evidence (Phillips canons) › Plain and ordinary meaning to a POSITATerm construed patent owner constructionDecided for patent owner

      “We are unpersuaded that we misconstrued the phrase “reconfiguring each remote radio unit by.” Petitioner’s proposed claim construction in the Rehearing Request does not give patentable weight to the claimed “reconfiguring each remote radio unit.” Although we agree with Petitioner that claim 1 requires limitations [b] and [c] (i.e., “determining a load percentage” and “increasing or decreasing the number of carriers”), we disagree with Petitioner that the term “by” before limitations [b] and [c] would require what comes before “by” to have no patentable weight. Rather, as stated in our Decision: we adopt the district court’s construction and construe “reconfiguring each remote radio unit” to be “changing the configuration of each remote unit.” We additionally note that the claim term requires that it is the remote radio unit itself that is changed because the “remote radio unit” is the direct object of the verb “reconfiguring.” This is consistent with the specification of the ’338 patent, which describes reconfiguring the RRUs themselves. Dec. 9–10 (citing Ex. 1001, 4:1–13, 7:16–31, 8:8–21, 8:48–55, 11:28–39).” slip op. at 7

    • Strike new argumentNew argument disregardedDecided for patent owner

      “In its rehearing request, Petitioner now newly argues that we overlooked Hettstedt’s disclosure that remote radio heads are channel-selective in the uplink (i.e., column 5, lines 6–8 of Hettstedt). But Petitioner’s new analysis and explanation that Hettstedt’s teaches “reconfiguring each remote radio unit head” because its radio units are channel selective in the uplink was not presented in the Petition, and we could not have overlooked arguments or evidence not before us.2 See 37 C.F.R. 42.71(d). A petition must include “a detailed explanation of the significance of the evidence.” 37 C.F.R. § 42.22(a)(2). We are not persuaded of any error in our Decision that Petitioner failed to demonstrate a reasonable likelihood of prevailing in establishing that claim 1 is anticipated by Hettstedt. See Dec. 13–15. 2 We acknowledge Petitioner’s reliance on Hettstedt’s column 5, lines 6–8 on page 21 of the Petition; however, the Petition relied on this portion of Hettstedt for Element F of claim 1 (“configuring each remote radio unit to receive or transmit a respective subset of the plurality of carriers, each respective subset of the plurality of carriers including a number of carriers”), not for Element G of claim 1 (“reconfiguring each remote radio unit by . . .”). See Pet. 21. Petitioner’s Rehearing Request also points to reliance on Hettstedt’s column 5, lines 6–8 on page 10 of the Petition and in paragraphs of Dr. Acampora’s testimony (see Req. Reh’g 6–8 (citing Pet. 10; Ex. 1003 ¶¶ 46–54)), however (i) page 10 of the Petition and paragraphs 46–52 of Dr. Acampora’s testimony are not addressing the “reconfiguring each remote radio unit” limitation, and (ii) while paragraphs 53–54 of Dr. Acampora’s testimony addresses the “reconfiguring each remote radio unit” these paragraphs do not reference Hettstedt’s column 5, lines 6–8. See Pet. 10; Ex. 1003 ¶¶ 46–54.” slip op. at 4

    Claim construction
    Patents in suitUS 8,682,338
  • PTAB · May 29, 2020 · IPR2019-01413 · APJ Karl D Easthom · IPR · Rehearing

    The Board denied Rovi Guides’ rehearing request, leaving institution of inter partes review of claims 1–22 in place because the request showed no matters misapprehended or overlooked.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “institute an inter partes review, the Board reviews its decision for an abuse of discretion. 37 C.F.R. § 42.71(c). The party requesting rehearing bears the burden of showing that the decision should be modified, and “[t]he request must specifically identify all matters the party believes the Board misapprehended or overlooked.” 37 C.F.R. § 42.71(d)” slip op. at 2

    • PTAB / AIA Trials › Constitutional / APA (Arthrex, Oil States, due process)Decided for petitioner

      “Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320 (Fed. Cir. 2019), did not warrant terminating or staying this case. Dec. 26–27. Specifically, we explained that, according to Arthrex, “no constitutional infirmity [exists] in an institution decision.” Id. at 27 (quoting Arthrex, 941 F.3d at 1340) (alteration in Decision). We also explained that we generally do not stay cases pending an appeal to the Federal Circuit or the Supreme Court. Id.” slip op. at 2

    None
    Patents in suitUS 9,232,254
  • PTAB · Mar 25, 2020 · IPR2019-00292 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s rehearing requests, leaving in place its denial of authorization to seek a stay or termination based on Arthrex.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “The party requesting rehearing has the burden to show that the decision should be modified. 37 C.F.R. § 42.71(d). Additionally, the request for rehearing “must specifically identify all matters the party believes the Board misapprehended or overlooked, and the place where each matter was previously addressed in a motion, an opposition, or a reply.” Id.” slip op. at 2

    None
    Patents in suitUS 7,937,394
  • PTAB · Mar 25, 2020 · IPR2019-00281 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s rehearing requests challenging the denial of authorization to seek a stay or termination based on Arthrex and the APA.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “The party requesting rehearing has the burden to show that the decision should be modified. 37 C.F.R. § 42.71(d). Additionally, the request for rehearing “must specifically identify all matters the party believes the Board misapprehended or overlooked, and the place where each matter was previously addressed in a motion, an opposition, or a reply.” Id.” slip op. at 2

    • PTAB / AIA Trials › Constitutional / APA (Arthrex, Oil States, due process)Decided for petitioner

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    None
    Patents in suitUS 9,621,956
  • PTAB · Mar 25, 2020 · IPR2019-00239 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s rehearing requests seeking authorization to move to stay or terminate the proceedings based on Arthrex and the APA.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    • PTAB / AIA Trials › Constitutional / APA (Arthrex, Oil States, due process)Decided for petitioner

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    None
    Patents in suitUS 7,779,011
  • PTAB · Mar 25, 2020 · IPR2019-00555 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s rehearing requests seeking authorization to move to stay or terminate the proceedings based on Arthrex and APA arguments.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    • PTAB / AIA Trials › Constitutional / APA (Arthrex, Oil States, due process)Decided for petitioner

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    None
    Patents in suitUS 9,668,014
  • PTAB · Mar 25, 2020 · IPR2019-00290 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s rehearing requests challenging denial of authorization to seek a stay or termination based on Arthrex and APA arguments.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “The party requesting rehearing has the burden to show that the decision should be modified. 37 C.F.R. § 42.71(d). Additionally, the request for rehearing “must specifically identify all matters the party believes the Board misapprehended or overlooked, and the place where each matter was previously addressed in a motion, an opposition, or a reply.” Id.” slip op. at 2

    None
    Patents in suitUS 7,937,394
  • PTAB · Mar 25, 2020 · IPR2019-00237 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s requests for rehearing of its denials of authorization to seek a stay or termination, rejecting the Arthrex and APA arguments.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “The party requesting rehearing has the burden to show that the decision should be modified. 37 C.F.R. § 42.71(d). Additionally, the request for rehearing “must specifically identify all matters the party believes the Board misapprehended or overlooked, and the place where each matter was previously addressed in a motion, an opposition, or a reply.” Id.” slip op. at 2

    • PTAB / AIA Trials › Constitutional / APA (Arthrex, Oil States, due process)Decided for petitioner

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    None
    Patents in suitUS 7,779,011
  • PTAB · Mar 25, 2020 · IPR2019-00231 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s requests for rehearing of its denials of authorization to seek a stay or termination, rejecting the Arthrex and APA arguments.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “The party requesting rehearing has the burden to show that the decision should be modified. 37 C.F.R. § 42.71(d). Additionally, the request for rehearing “must specifically identify all matters the party believes the Board misapprehended or overlooked, and the place where each matter was previously addressed in a motion, an opposition, or a reply.” Id.” slip op. at 2

    • PTAB / AIA Trials › Constitutional / APA (Arthrex, Oil States, due process)Decided for petitioner

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    None
    Patents in suitUS 9,369,741
  • PTAB · Mar 25, 2020 · IPR2019-00224 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s rehearing requests challenging denial of authorization to seek a stay or termination based on Arthrex and the APA.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    • PTAB / AIA Trials › Constitutional / APA (Arthrex, Oil States, due process)Decided for petitioner

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    None
    Patents in suitUS 7,827,585
Page 1 of 5
← Previous12345Next →

Holdings, summaries, rulings, issues, outcomes, winners and claim constructions shown for a decision were generated by a large language model reading the opinion. They are a guide to the decision, not the decision. Confirm every one against the court's own text before relying on it. Outcomes read from the patent owner’s side. Party names are extracted from the decision and are missing on about 900 short Director denials and scans, which carry the trial number instead.